In that vein, let's learn about the three most important things you should know if you're going to consider investing in ...
Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...
"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...
While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...
Moderna Inc (MRNA) stock saw a modest uptick, ending the day at $38.5 which represents a slight increase of $2.61 or 7.27% from the prior close of $35.89. The stock opened at $36.35 and touched a low ...
Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...
Key Takeaways U.S. equities rose at midday Tuesday on optimism that the new tariffs threatened by President Trump won't be as ...
Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...
Shares of Moderna plunged 20% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its ...
Moderna lowered its 2025 sales guidance by roughly $1 billion, as it continues to cut costs. The biotech company now ...
Moderna won an agreement for its Covid vaccines in Europe on Friday, but Moderna stock reversed its early gains.